At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $25.73M, above the global median of $18.58M
- FinancialsAltman Z-Score 4.3: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.50%Below 5Y avg (0.62%)
Annual Rate
CNY 0.10Paid semi-annual
Payout Ratio
54.6%Sustainable
Last Ex-Dividend
Nov 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.71BCNY406.03M · vs all stocks (USD)
Trailing P/E
45.68xRevenue (TTM)
917.38MCNY137.48M · vs all stocks (USD)
Profit Margin
6.87%Beta
-0.1820xvs all stocks
52-Week Change
-20.72%vs all stocks
Forward Annual Dividend Yield
0.50%vs all stocks
Market Capitalization
2.71BCNY406.03M · vs all stocks (USD)
Enterprise Value
1.59BCNY238.58M · vs all stocks (USD)
Trailing P/E
45.68xPrice to Sales (TTM)
3.00xPrice to Book (MRQ)
1.61xEnterprise to Revenue
1.74xEnterprise to EBITDA
14.78xGross Margin
60.91%Profit Margin
6.87%Operating Margin
7.47%Return on Assets (TTM)
1.83%Return on Equity (TTM)
3.71%Revenue (TTM)
917.38MCNY137.48M · vs all stocks (USD)
Revenue per Share (TTM)
6.67CNYUpdated Nov 19, 2026Quarterly Revenue Growth
-26.90%Gross Profit (TTM)
504.82MCNY75.65M · vs all stocks (USD)
EBITDA (TTM)
124.30MCNY18.63M · vs all stocks (USD)
Net Income (TTM)
63.02MCNY9.44M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-52.20%Operating Cash Flow (TTM)
213.66MCNY32.02M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
171.66MCNY25.73M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1000CNYUpdated Nov 19, 2026Forward Annual Dividend Yield
0.50%vs all stocks
Trailing Annual Dividend Rate
0.1500CNYUpdated Nov 19, 2026Trailing Annual Dividend Yield
0.76%vs all stocks
5-Year Average Dividend Yield
0.62%vs all stocks
Payout Ratio
54.62%Minority Interest (Equity)
2.20MCNYFY2025 · Dec 31, 2025Revenue
1.14BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
549.08MCNYFY2025 · Dec 31, 2025Gross Profit
591.79MCNYFY2025 · Dec 31, 2025Operating Income
122.28MCNY18.32M · vs all stocks (USD)
Pre-tax Income
108.95MCNYFY2025 · Dec 31, 2025Income Tax Expense
12.93MCNYFY2025 · Dec 31, 2025Net Income
96.02MCNYFY2025 · Dec 31, 2025EBIT
111.14MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
172.28MCNYFY2025 · Dec 31, 2025Research & Development
53.11MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
334.71MCNYFY2025 · Dec 31, 2025Other Operating Expenses
12.29MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
14.55MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
2.18MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7077CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7077CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
136.05MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
136.05MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
96.02MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
257.86KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-42.37MCNYFY2025 · Dec 31, 2025Free Cash Flow
-84.50MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.09BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
96.02MCNYFY2025 · Dec 31, 2025Other Non-cash Items
2.74MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-121.29MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-19.85MCNYFY2025 · Dec 31, 2025Capital Expenditures
-42.12MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-42.12MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
50.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-101.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-43.89MCNYFY2025 · Dec 31, 2025Other Financing Charges
-478.47KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-95.37MCNYFY2025 · Dec 31, 2025Shares Outstanding
138.17MSharesUpdated Nov 19, 2026Float Shares
83.63MSharesUpdated Nov 19, 2026% Held by Insiders
40.99%vs all stocks
% Held by Institutions
4.38%vs all stocks
Total Cash (MRQ)
1.16BCNY173.38M · vs all stocks (USD)
Total Cash per Share (MRQ)
8.48CNYUpdated Nov 19, 2026Total Debt (MRQ)
3.16MCNY473.53K · vs all stocks (USD)
Current Ratio (MRQ)
3.79xBook Value per Share (MRQ)
12.49CNYUpdated Nov 19, 2026Total Assets
2.32BCNY348.09M · vs all stocks (USD)
Total Current Assets
1.80BCNYFY2025 · Dec 31, 2025Total Liabilities
633.75MCNYFY2025 · Dec 31, 2025Total Non-current Assets
520.01MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
109.60MCNYFY2025 · Dec 31, 2025Total Current Liabilities
524.15MCNYFY2025 · Dec 31, 2025Cash
1.09BCNYFY2025 · Dec 31, 2025Cash Equivalents
65.78KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.09BCNYFY2025 · Dec 31, 2025Accounts Receivable
423.39MCNYFY2025 · Dec 31, 2025Inventory
110.82MCNYFY2025 · Dec 31, 2025Accounts Payable
127.57MCNYFY2025 · Dec 31, 2025Short-term Debt
98.88MCNYFY2025 · Dec 31, 2025Other Current Liabilities
523.51KCNYFY2025 · Dec 31, 2025Long-term Debt
1.95MCNYFY2025 · Dec 31, 2025Common Stock (Book)
106.28MCNYFY2025 · Dec 31, 2025Retained Earnings
703.10MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.69BCNY253.12M · vs all stocks (USD)
Treasury Stock
25.08MCNYFY2025 · Dec 31, 202552-Week Low
19.00CNYUpdated Nov 19, 202652-Week High
30.85CNYUpdated Nov 19, 202652-Week Change
-20.72%vs all stocks
Beta
-0.1820xvs all stocks
50-Day MA
20.77CNYUpdated Nov 19, 2026200-Day MA
22.78CNYUpdated Nov 19, 2026Avg 10-Day Volume
11.63MSharesUpdated Nov 19, 2026Avg 30-Day Volume
5.14MSharesUpdated Nov 19, 2026Diluted EPS (TTM)
0.4400CNYUpdated Nov 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.61Profit Margin: 0.07
Financial Health
Altman Z-Score 4.3: safe zoneNotable
Altman Z-Score: 4.30
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $25.73M, above the global median of $18.58MNotable
Levered free cash flow (USD): 25,725,617.393Global Median: 18,579,867.004
Companies that share the same coordination system — how they create, deliver, or capture value.
Yantai Zhenghai Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Universal Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Kamada Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Haisen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Seers Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tilray Brands, Inc.
Tier 1ProductionApproval-Gated PipelineFlowAttention
Clarity Pharmaceuticals Ltd
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Tibet Aim Pharm Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Medlander Medical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Assembly Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk